Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib in Parkinson's Disease
NCT03205488Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Oct 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nilotinib in Parkinson's disease (PD), sponsored by Northwestern University. Started Oct 2017; status: completed.
02
Drugs
nilotinib
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03205488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03205488.